PHAT
PHATHOM PHARMACEUTICALS INC
Latest close $8.48 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 3 parsed filing(s)| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 29, 2026 filed · 29d Initial Schedule 13G | Initial Schedule 13G | 4.4M +1.3M | 12.00% +6.80 pts | $10.85 | $11.64 | $8.48 |
| BlackRock CIK0002012383 | Sep 30, 2024 quarter end Nov 13, 2024 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 3.1M | $8.48 | |||
| BlackRock CIK0002012383 | Sep 30, 2024 observed Nov 12, 2024 filed · 43d Initial Schedule 13G | Initial Schedule 13G | 3.1M | 5.20% | $8.48 |